IMPACT IS RESEARCH +
We Bring Together and Fund the Best Innovators
Research in silos is ineffective. Our initiatives not only fund some of the most promising researchers, but also create programs bringing key medical professionals together to agree upon road maps with explicit coordinated milestones. Required research community consensus, priorities and funding needs are addressed comprehensively. .
Research in silos is ineffective. Our initiatives not only fund some of the most promising researchers, but also create programs bringing key medical professionals together to agree upon road maps with explicit coordinated milestones. Required research community consensus, priorities and funding needs are addressed comprehensively. .
JENNIFER PIETENPOL, PhD |
HEATHER CUNLIFFE, PhD |
BRYAN SCHNEIDER, PhD |
Research & Thought Leadership We Support Includes:
Landmark Tool for Diagnosing Inflammatory Breast Cancer
Published for peer review in Breast Cancer Research and Treatment (See Article Here)
Authors: R. Jagsi, G. Mason, B. A. Overmoyer, W. A. Woodward, S. Badve, R. J. Schneider, J. E. Lang, M. Alpaugh, K. P. Williams, D. Vaught, A. Smith, K. Smith, K. D. Miller
Three party collective action collaboration between Milburn Foundation, Susan G. Komen and IBC Research Foundation
Background on Breast Cancer Research and Treatment:
Breast Cancer Research and Treatment provides the surgeon, radiotherapist, medical oncologist, endocrinologist, epidemiologist, immunologist or cell biologist investigating problems in breast cancer a single forum for communication. The journal creates a "market place" for breast cancer topics which cuts across all the usual lines of disciplines, providing a site for presenting pertinent investigations, and for discussing critical questions relevant to the entire field. It seeks to develop a new focus and new perspectives for all those concerned with breast cancer.
Marker Discovery and Validation in a Prospectively Collected IBC Cohort
John Martens, Ph.D
Erasmus Universitair Medisch Centrum Rotterdam
A Susan G. Komen grant, supported by the Milburn Foundation and IBC Research Foundation
Function of Lymphatic Vessels in Rapid Progression of Inflammatory Breast Cancer
Mihaela Skobe, Ph.D
The Icahn School of Medicine at Mount Sinai
A Susan G. Komen grant, supported by the Milburn Foundation and IBC Research Foundation
Triple Negative Breast Cancer: Subtypes, Molecular Targets and Therapeutic Approaches
Jennifer Pietenpol, PhD
A Susan G. Komen grant, supported in part by the Milburn Foundation
Translational Genomics (TGen): Molecular Characterization of TNIBC
Heather Cunliffe, PhD
An IBC Research Foundation grant, supported by the Milburn Foundation
Underlying Molecular Underpinning of Inflammatory Breast Cancer using Next Generation Sequencing
Bryan Schneider, PhD and Milan Racovich, PhD
An IBC Research Foundation grant, supported by the Milburn Foundation
Identifying Potential Therapeutic Targets in Inflammatory Breast Cancer Following Neoadjuvant Chemotherapy
Dr. Robert J. Schneider
NYU Medical Center
An IBC Research Foundation grant, supported by the Milburn Foundation
Validation of Jak2 as Novel Therapeutic Target in Triple Negative Inflammatory Breast Cancer
Dr. Beth Overmoyer
Dana Farber Cancer Institute (Harvard)
An IBC Research Foundation grant, supported by the Milburn Foundation
Translating mTOR and Translational Regulation to Therapy in Triple Negative Inflammatory Breast Cancer
Robert J. Schneider, PhD
NYU Medical Center
An IBC Research Foundation grant, supported by the Milburn Foundation
Development of Mouse Models of Inflammatory Breast Cancer Brain Metastasis
Diane Palmieri, PhD.
National Cancer Institure
An IBC Research Foundation grant, supported by the Milburn Foundation
Landmark Tool for Diagnosing Inflammatory Breast Cancer
Published for peer review in Breast Cancer Research and Treatment (See Article Here)
Authors: R. Jagsi, G. Mason, B. A. Overmoyer, W. A. Woodward, S. Badve, R. J. Schneider, J. E. Lang, M. Alpaugh, K. P. Williams, D. Vaught, A. Smith, K. Smith, K. D. Miller
Three party collective action collaboration between Milburn Foundation, Susan G. Komen and IBC Research Foundation
Background on Breast Cancer Research and Treatment:
Breast Cancer Research and Treatment provides the surgeon, radiotherapist, medical oncologist, endocrinologist, epidemiologist, immunologist or cell biologist investigating problems in breast cancer a single forum for communication. The journal creates a "market place" for breast cancer topics which cuts across all the usual lines of disciplines, providing a site for presenting pertinent investigations, and for discussing critical questions relevant to the entire field. It seeks to develop a new focus and new perspectives for all those concerned with breast cancer.
Marker Discovery and Validation in a Prospectively Collected IBC Cohort
John Martens, Ph.D
Erasmus Universitair Medisch Centrum Rotterdam
A Susan G. Komen grant, supported by the Milburn Foundation and IBC Research Foundation
Function of Lymphatic Vessels in Rapid Progression of Inflammatory Breast Cancer
Mihaela Skobe, Ph.D
The Icahn School of Medicine at Mount Sinai
A Susan G. Komen grant, supported by the Milburn Foundation and IBC Research Foundation
Triple Negative Breast Cancer: Subtypes, Molecular Targets and Therapeutic Approaches
Jennifer Pietenpol, PhD
A Susan G. Komen grant, supported in part by the Milburn Foundation
Translational Genomics (TGen): Molecular Characterization of TNIBC
Heather Cunliffe, PhD
An IBC Research Foundation grant, supported by the Milburn Foundation
Underlying Molecular Underpinning of Inflammatory Breast Cancer using Next Generation Sequencing
Bryan Schneider, PhD and Milan Racovich, PhD
An IBC Research Foundation grant, supported by the Milburn Foundation
Identifying Potential Therapeutic Targets in Inflammatory Breast Cancer Following Neoadjuvant Chemotherapy
Dr. Robert J. Schneider
NYU Medical Center
An IBC Research Foundation grant, supported by the Milburn Foundation
Validation of Jak2 as Novel Therapeutic Target in Triple Negative Inflammatory Breast Cancer
Dr. Beth Overmoyer
Dana Farber Cancer Institute (Harvard)
An IBC Research Foundation grant, supported by the Milburn Foundation
Translating mTOR and Translational Regulation to Therapy in Triple Negative Inflammatory Breast Cancer
Robert J. Schneider, PhD
NYU Medical Center
An IBC Research Foundation grant, supported by the Milburn Foundation
Development of Mouse Models of Inflammatory Breast Cancer Brain Metastasis
Diane Palmieri, PhD.
National Cancer Institure
An IBC Research Foundation grant, supported by the Milburn Foundation